Showing 1 - 7 results of 7 for search 'Tamra E Werbowetski-Ogilvie', query time: 0.04s Refine Results
  1. 1
    Pluripotent transcription factors possess distinct roles in normal versus transformed human stem cells.

    Pluripotent transcription factors possess distinct roles in normal versus transformed human stem cells. by Junfeng Ji, Tamra E Werbowetski-Ogilvie, Bonan Zhong, Seok-Ho Hong, Mickie Bhatia

    Published 2009-11-01
    Get full text
    Article
  2. 2
    Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression

    Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression by Stephanie Borlase, Alexandria DeCarlo, Ludivine Coudière-Morrison, Lisa Liang, Christopher J. Porter, Vijay Ramaswamy, Tamra E. Werbowetski-Ogilvie

    Published 2023-09-01
    Get full text
    Article
  3. 3
    Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells

    Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells by Amani I. Moraya, Jennifer L. Ali, Pranati Samadder, Lisa Liang, Ludivine Coudière Morrison, Tamra E. Werbowetski-Ogilvie, Makanjuola Ogunsina, Frank Schweizer, Gilbert Arthur, Mark W. Nachtigal

    Published 2017-05-01
    Get full text
    Article
  4. 4
    Deconstruction of Medulloblastoma Cellular Heterogeneity Reveals Differences between the Most Highly Invasive and Self-Renewing Phenotypes

    Deconstruction of Medulloblastoma Cellular Heterogeneity Reveals Differences between the Most Highly Invasive and Self-Renewing Phenotypes by Ludivine Coudière Morrison, Robyn McClelland, Christopher Aiken, Melissa Bridges, Lisa Liang, Xin Wang, Domenico Di Curzio, Marc R. Del Bigio, Michael D. Taylor, Tamra E. Werbowetski-Ogilvie

    Published 2013-04-01
    Get full text
    Article
  5. 5
    Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma

    Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma by Margaret Stromecki, Nazanin Tatari, Ludivine Coudière Morrison, Ravinder Kaur, Jamie Zagozewski, Gareth Palidwor, Vijay Ramaswamy, Patryk Skowron, Matthias Wölfl, Till Milde, Marc R. Del Bigio, Michael D. Taylor, Tamra E. Werbowetski‐Ogilvie

    Published 2018-04-01
    Get full text
    Article
  6. 6
    Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma

    Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma by Emma Martell, Helgi Kuzmychova, Esha Kaul, Harshal Senthil, Subir Roy Chowdhury, Ludivine Coudière Morrison, Agnes Fresnoza, Jamie Zagozewski, Chitra Venugopal, Chris M. Anderson, Sheila K. Singh, Versha Banerji, Tamra E. Werbowetski-Ogilvie, Tanveer Sharif

    Published 2023-05-01
    Get full text
    Article
  7. 7
    Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression

    Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression by Jamie Zagozewski, Stephanie Borlase, Brent J. Guppy, Ludivine Coudière-Morrison, Ghazaleh M. Shahriary, Victor Gordon, Lisa Liang, Stephen Cheng, Christopher J. Porter, Rhonda Kelley, Cynthia Hawkins, Jennifer A. Chan, Yan Liang, Jingjing Gong, Carolina Nör, Olivier Saulnier, Robert J. Wechsler-Reya, Vijay Ramaswamy, Tamra E. Werbowetski-Ogilvie

    Published 2022-07-01
    Get full text
    Article

Search Tools: